{"id":8345,"date":"2025-06-05T11:34:42","date_gmt":"2025-06-05T03:34:42","guid":{"rendered":"https:\/\/regask.com\/?p=8345"},"modified":"2025-07-17T10:53:12","modified_gmt":"2025-07-17T02:53:12","slug":"impulsando-ensayos-hibridos-globales-simplificados-compatibles-y-escalables","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/","title":{"rendered":"Impulsando ensayos cl\u00ednicos h\u00edbridos globales: simplificados y co..."},"content":{"rendered":"<h4><strong>El desaf\u00edo<\/strong><\/h4>\n<p class=\"p1\">Una empresa farmac\u00e9utica l\u00edder a nivel mundial se preparaba para ampliar los ensayos cl\u00ednicos h\u00edbridos de su producto Alimentos para Fines M\u00e9dicos Especiales (FSMP). Sin embargo, la diversidad y la evoluci\u00f3n de las regulaciones regionales supusieron un importante obst\u00e1culo para la ampliaci\u00f3n eficaz de los ensayos.<\/p>\n<p class=\"p1\">Los marcos regulatorios para los ensayos cl\u00ednicos h\u00edbridos y descentralizados (ECD) var\u00edan significativamente en todo el mundo y no existe un manual armonizado.<\/p>\n<p class=\"p1\">Los requisitos de consentimiento electr\u00f3nico, herramientas de salud digital, visitas de profesionales de la salud a domicilio (HHCP), monitoreo remoto y privacidad de datos difieren sustancialmente seg\u00fan la jurisdicci\u00f3n. El desaf\u00edo no fue solo c\u00f3mo ejecutar los ensayos, sino comprender qu\u00e9 regulaciones se aplicaban en cada pa\u00eds, lo que resalta la necesidad de manuales regulatorios espec\u00edficos para guiar la implementaci\u00f3n local.<\/p>\n<h4 data-start=\"781\" data-end=\"933\"><\/h4>\n<h4 data-start=\"781\" data-end=\"933\"><strong data-start=\"781\" data-end=\"804\">El enfoque RegASK<\/strong><\/h4>\n<p><span data-teams=\"true\">RegASK, al combinar su <a href=\"https:\/\/regask.com\/es\/producto\/#RegGenius:~:text=Book%20a%20demo-,RegGenius,-Your%20GenAI%20co\">Soluci\u00f3n de inteligencia regulatoria impulsada por IA<\/a> Con su profundo conocimiento del dominio, aport\u00f3 estructura a la complejidad.<\/span><\/p>\n<p>Entregamos un conjunto de <strong>Gu\u00edas regulatorias del DCT<\/strong> Para 27 mercados estrat\u00e9gicos. Cada gu\u00eda inclu\u00eda:<\/p>\n<ul>\n<li>Informaci\u00f3n clara, validada y procesable sobre las regulaciones locales de DCT<\/li>\n<li>Comparaciones entre pa\u00edses para evaluar los requisitos regulatorios y la preparaci\u00f3n<\/li>\n<li>Navegaci\u00f3n pr\u00e1ctica de preguntas y respuestas para apoyar a los equipos de operaciones cl\u00ednicas y regulatorios<\/li>\n<li>Actualizaciones continuas para mantener a los equipos alineados con los cambiantes panoramas regulatorios<\/li>\n<\/ul>\n\t<div id=\"gap-30066574\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-30066574 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><strong>Aspectos destacados clave<\/strong><\/h4>\n\t<div id=\"gap-1799109826\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1799109826 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n\t<div id=\"stack-3194632729\" class=\"stack stack-row justify-start items-stretch\">\n\t\t\n<div class=\"row equal-height-row\"  id=\"row-1137047671\">\n\n\t<div id=\"col-1483901762\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner text-left dark\" style=\"background-color:rgb(10, 35, 66);\" >\n\t\t\t\n\t\t\t\n<h1>27<\/h1>\n<p>jurisdicciones cubiertas<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1483901762 > .col-inner {\n  padding: 10% 10% 10% 10%;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-226539076\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner\" style=\"background-color:#e5e8fb;\" >\n\t\t\t\n\t\t\t\n<h1>90%<\/h1>\n<p>Tiempo ahorrado para compilar las regulaciones del pa\u00eds<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-226539076 > .col-inner {\n  padding: 10% 10% 10% 10%;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-653609422\" class=\"col medium-4 small-12 large-4\"  >\n\t\t\t\t<div class=\"col-inner dark\" style=\"background-color:#0a2342;\" >\n\t\t\t\n\t\t\t\n<h1>Facilidad<\/h1>\n<p>para acceder a los datos<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-653609422 > .col-inner {\n  padding: 10% 10% 10% 10%;\n  border-radius: 16px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n<style>\n#row-1137047671 > .col > .col-inner {\n  background-color: #0a2342;\n  border-radius: 14px;\n}\n<\/style>\n<\/div>\n\t\t\n<style>\n#stack-3194632729 > * {\n  --stack-gap: 0rem;\n}\n<\/style>\n\t<\/div>\n\t\n<a href=\"https:\/\/regask.com\/es\/contacto\/\" class=\"button primary\" >\n\t\t<span>Conozca m\u00e1s sobre el enfoque RegASK con nuestro Equipo<\/span>\n\t<\/a>\n\n\t<div id=\"gap-1180987689\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1180987689 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><strong>El resultado<\/strong><\/h4>\n<p>RegASK permiti\u00f3 una planificaci\u00f3n y ejecuci\u00f3n de pruebas m\u00e1s r\u00e1pida y segura mediante:<\/p>\n<ul>\n<li>Permiti\u00f3 una toma de decisiones m\u00e1s r\u00e1pida y basada en evidencia sobre el dise\u00f1o de ensayos y la estrategia de lanzamiento. Empoder\u00f3 a los equipos cl\u00ednicos y regulatorios con inteligencia localizada y actualizada.<\/li>\n<li>Se elimin\u00f3 la investigaci\u00f3n manual que consum\u00eda mucho tiempo en varios pa\u00edses<\/li>\n<li>Implementaci\u00f3n de ensayos cl\u00ednicos h\u00edbridos escalables y compatibles con las normas en los mercados globales<\/li>\n<\/ul>\n<p><strong>Desde la incertidumbre regulatoria hasta la ventaja competitiva, RegASK brind\u00f3 claridad, confianza y velocidad.<\/strong><\/p>\n\t<div id=\"gap-1511786415\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1511786415 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<div class=\"is-divider divider clearfix\" style=\"max-width:100%;height:2px;background-color:rgb(197, 202, 236);\"><\/div>\n\t<div id=\"gap-1336017551\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1336017551 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Preguntas frecuentes<\/h2>\n\t<div id=\"gap-661903717\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-661903717 {\n  padding-top: 30px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><strong>P1: \u00bfC\u00f3mo ayuda la norma RegASK a simplificar el cumplimiento de la DCT en todos los pa\u00edses?<\/strong><\/h4>\n<p>RegASK simplifica el cumplimiento normativo en la implementaci\u00f3n de ensayos cl\u00ednicos al proporcionar informaci\u00f3n clara y validada sobre los requisitos regulatorios espec\u00edficos de cada pa\u00eds. Nuestras gu\u00edas, elaboradas por expertos, y nuestra plataforma de inteligencia global ayudan a las partes interesadas a comprender las normativas locales para componentes descentralizados como el consentimiento electr\u00f3nico, la telemedicina y la monitorizaci\u00f3n remota, lo que permite estrategias de ensayo consistentes y compatibles con la normativa en diversos entornos regulatorios.<\/p>\n<h4><\/h4>\n<h4><strong>Pregunta 2: <span data-teams=\"true\">\u00bfQu\u00e9 contenidos cubren las Gu\u00edas Regulatorias?<\/span><\/strong><\/h4>\n<p>Las Gu\u00edas Regulatorias de RegASK ofrecen informaci\u00f3n espec\u00edfica para cada pa\u00eds sobre el panorama de los ensayos cl\u00ednicos, abarcando el proceso del comit\u00e9 de \u00e9tica, los plazos y elementos descentralizados como el consentimiento electr\u00f3nico, la firma electr\u00f3nica y el manejo de datos. Facilitan la planificaci\u00f3n y la gesti\u00f3n regulatoria de ensayos en los mercados objetivo.<\/p>\n<h4><\/h4>\n<h4><strong>P3: \u00bfC\u00f3mo se mantiene RegASK a la vanguardia de las regulaciones que cambian r\u00e1pidamente?<\/strong><\/h4>\n<p>RegASK se mantiene a la vanguardia de las regulaciones que cambian r\u00e1pidamente mediante una combinaci\u00f3n de:<\/p>\n<p>\u2022 herramientas de monitoreo avanzadas impulsadas por IA<br \/>\n\u2022 una red global de expertos regulatorios<br \/>\n\u2022 an\u00e1lisis continuo de actualizaciones oficiales y tendencias de la industria<\/p>\n<p>Esto nos permite ofrecer informaci\u00f3n validada casi en tiempo real que ayuda a los clientes a adaptarse r\u00e1pidamente y mantener el cumplimiento en todos los mercados.<\/p>","protected":false},"excerpt":{"rendered":"<p>The Challenge A leading global pharmaceutical company was preparing to scale hybrid clinical trials for its Food for Special Medical Purposes (FSMP) product. However, the diverse and evolving regional regulations posed a major hurdle to scaling the trials effectively. Regulatory frameworks for hybrid and decentralized clinical trials (DCTs) vary significantly across the globe, and no&#8230;<\/p>","protected":false},"author":43,"featured_media":8358,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17,527,18,21],"tags":[197],"class_list":["post-8345","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-case-study","category-united-states-regulations","category-food-and-beverage","category-pharma-and-biotech","tag-infant-formula"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>US | Decentralized Clinical Trials for FSMP | Case Study | RegASK<\/title>\n<meta name=\"description\" content=\"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/impulsando-ensayos-hibridos-globales-simplificados-compatibles-y-escalables\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Powering Global Hybrid Clinical Trials: Simplified, Compliant, and Scalable\" \/>\n<meta property=\"og:description\" content=\"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/impulsando-ensayos-hibridos-globales-simplificados-compatibles-y-escalables\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T03:34:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-17T02:53:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Powering Global Hybrid Clinical Trials: Simplified, Com&hellip;\",\"datePublished\":\"2025-06-05T03:34:42+00:00\",\"dateModified\":\"2025-07-17T02:53:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\"},\"wordCount\":511,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"keywords\":[\"Infant Formula\"],\"articleSection\":[\"Case Studies\",\"United States\",\"Food and Nutrition\",\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\",\"name\":\"US | Decentralized Clinical Trials for FSMP | Case Study | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"datePublished\":\"2025-06-05T03:34:42+00:00\",\"dateModified\":\"2025-07-17T02:53:12+00:00\",\"description\":\"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/powering-global-hybrid-trials-simplified-compliant-and-scalable\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/global-hybrid-trials-simplified-compliant-scalable-1.png\",\"width\":800,\"height\":600,\"caption\":\"Global Hybrid Trials Simplified Compliant Scalable 1\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EE. UU. | Ensayos cl\u00ednicos descentralizados para FSMP | Caso pr\u00e1ctico | RegASK","description":"Descubra c\u00f3mo RegASK habilit\u00f3 ensayos cl\u00ednicos h\u00edbridos globales con inteligencia regulatoria personalizada, simplificando el cumplimiento y acelerando la ejecuci\u00f3n de los ensayos.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/impulsando-ensayos-hibridos-globales-simplificados-compatibles-y-escalables\/","og_locale":"es_ES","og_type":"article","og_title":"Powering Global Hybrid Clinical Trials: Simplified, Compliant, and Scalable","og_description":"Learn how RegASK enabled global hybrid clinical trials with tailored regulatory intelligence\u2014simplifying compliance and accelerating trial execution.","og_url":"https:\/\/regask.com\/es\/impulsando-ensayos-hibridos-globales-simplificados-compatibles-y-escalables\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-06-05T03:34:42+00:00","article_modified_time":"2025-07-17T02:53:12+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#article","isPartOf":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Powering Global Hybrid Clinical Trials: Simplified, Com&hellip;","datePublished":"2025-06-05T03:34:42+00:00","dateModified":"2025-07-17T02:53:12+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/"},"wordCount":511,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","keywords":["Infant Formula"],"articleSection":["Case Studies","United States","Food and Nutrition","Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/","url":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/","name":"EE. UU. | Ensayos cl\u00ednicos descentralizados para FSMP | Caso pr\u00e1ctico | RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","datePublished":"2025-06-05T03:34:42+00:00","dateModified":"2025-07-17T02:53:12+00:00","description":"Descubra c\u00f3mo RegASK habilit\u00f3 ensayos cl\u00ednicos h\u00edbridos globales con inteligencia regulatoria personalizada, simplificando el cumplimiento y acelerando la ejecuci\u00f3n de los ensayos.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/powering-global-hybrid-trials-simplified-compliant-and-scalable\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/06\/global-hybrid-trials-simplified-compliant-scalable-1.png","width":800,"height":600,"caption":"Global Hybrid Trials Simplified Compliant Scalable 1"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/8345","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=8345"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/8345\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/8358"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=8345"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=8345"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=8345"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}